Pure Global
NCT03495830

Stratification of Patient With Carotid Disease

Observational Multicentre Clinical Trial for Validation of Taxinomisis, New Stratification Tool for Stroke Risk in Patients With Carotid Disease
University of Belgrade·ClinicalTrials.gov·procedure
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carotid Artery Stenosis
Drug/Device/Intervention
Carotid endarterectomy
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
University of Belgrade
Location
Munich,Utrecht,Belgrade,Barcelona, Germany,Netherlands,Serbia,Spain
Timeline & enrollment
Phase
N/A
Start date
Mar 29, 2018
End date
Sep 01, 2022
Enrollment
270 participants
Primary outcome

Combined stroke, transitory ischemic attach and retinal transitory ischemic attach

Summary

Introduction: Taxinomisis trial is part of the Taxinomisis project. The concept of the
 Taxinomisis project is to stratify carotid artery disease relying on new modern data
 corresponding to contemporary patients based on information from longitudinal studies.
 Taxinomisis trial will validate this tool and adjust such stratification. Initial step of the
 project is characterization of symptomatic and asymptomatic carotid atherosclerotic plaque
 lesions, identification of risk and susceptibility factors through the exploitation of
 longitudinal cohort data and multiomics and disintegration of carotid artery disease
 phenotypes into endotypes through joint modeling of multipleomics data sets and systems
 medicine approaches. Finally such stratification model will be validated and adjusted in the
 Taxinomisis clinical trial.

ICD-10 classifications
Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03495830
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03495830 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Belgrade and is currently status unknown. The study focuses on Carotid Artery Stenosis. Target enrollment is 270 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.